OUTCOMES AFTER TRACHEOSTOMY IN CRITICALLY ILL PATIENTS WITH COVID-19 TREATED IN AN INTENSIVE CARE CENTER FOR TREATMENT OF CRITICALLY ILL PATIENTS WITH COVID-19 OPERATED BY BACH MAI HOSPITAL
Main Article Content
Abstract
Objective: To investigate the clinical characteristics, outcomes, and complications after tracheostomy in critically ill adult patients with COVID-19. Methods: We performed a retrospective study on critically ill patients with COVID-19 in the Intensive Care Center for Treating Critically Ill Patients with COVID-19 operated by Bach Mai Hospital in Ho Chi Minh City between September and October 2021. Results: Of 17 patients, 64.7% (11/17) were female, and 70.1% (12/17) were 50 or older. Common comorbidities included hypertension (41.2%; 7/17) and diabetes mellitus (35.3%; 6/17). Most patients had a late tracheostomy (70.6%; 12/17), and only 5/17 (29.4%) had an early tracheostomy. The method for performing tracheostomy was the open surgical technique (100%; 17/17). All healthcare staff wore a piece of personal protective equipment (PPE), an N95 respirator mask, and a protective face shield, and no healthcare staff was infected with COVID-19 by patients. Complications after tracheostomy included dislodged tracheostomy tube (1/17; 5.9%) and subcutaneous emphysema (1/17; 5.9%). Hospital all-cause mortality was 70.1% (12/17). Conclusion: Our study showed that the mean age of critically ill adult patients with COVID-19 was relatively high. The most common documented comorbidities included hypertension and diabetes mellitus. Complications after tracheostomy were rare, but hospital all-cause mortality was very high.
Article Details
Keywords
COVID-19; Tracheotomy
References
2. Williams T. và McGrath B. A. (2021). Tracheostomy for COVID-19: evolving best practice. Critical Care, 25 (1), 316.
3. Pauli N., Eeg-Olofsson M. và Bergquist H. (2021). Tracheotomy in COVID-19 patients: A retrospective study on complications and timing. Laryngoscope Investig Otolaryngol, 6 (3), 446-452.
4. World Health Organization (WHO) (2020). Public health surveillance for COVID-19: interim guidance., WHO, , September 22.
5. World Health Organization (WHO) (2021). Therapeutics and COVID-19: living guideline, WHO, , September 22.
6. Zhang X., Huang Q., Niu X. et al. (2020). Safe and effective management of tracheostomy in COVID-19 patients. Head Neck, 42 (7), 1374-1381.
7. Avilés-Jurado F. X., Prieto-Alhambra D., González-Sánchez N. et al. (2021). Timing, Complications, and Safety of Tracheotomy in Critically Ill Patients With COVID-19. JAMA Otolaryngology–Head & Neck Surgery, 147 (1), 41-48.
8. Wang J., Zhou M. và Liu F. (2020). Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. J Hosp Infect, 105 (1), 100-101.
9. Battaglini D., Missale F., Schiavetti I. et al. (2021). Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study. J Clin Med, 10 (12), 2651.
10. Umeh C., Tuscher L., Ranchithan S. et al. (2022). Predictors of COVID-19 Mortality in Critically Ill ICU Patients: A Multicenter Retrospective Observational Study. Cureus, 14 (1), e20952.